Successful treatment of pityriasis rubra pilaris with risankizumab, a IL-23/p19 antagonist.
Anne-Laure FouargeMarie CuvelierCharlotte Roquet-GravyLaurence de MontjoyeMarie BaeckPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases